Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Mauro Moscucci, MD;David W. Muller, MD;Charles M. Watts, MD;Vinita Bahl, DMD;Eric R. Bates, MD;Steven W. Werns, MD;Eva Kline-Rogers, R;

Publication

Article

May 1, 2003

The American Journal of Managed Care

May 2003

Volume9

Issue 5

Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Author(s):

Mauro Moscucci, MD,David W. Muller, MD

Download PDF: Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Articles in this issue

Lansoprazole Overutilization: Methods for Step-Down Therapy

Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Evaluation of a Depression Health Management Program to Improve Outcomes in First or Recurrent Episode Depression

A Prediction Model for Targeting Low-Cost, High-Risk Members of Managed Care Organizations

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Newsletter